US Bancorp’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-594
| Closed | -$31K | – | 3956 |
|
|
2020
Q3 | $31K | Hold |
594
| – | – | ﹤0.01% | 2622 |
|
|
2020
Q2 | $37K | Sell |
594
-50
| -8% | -$2.89K | ﹤0.01% | 2547 |
|
|
2020
Q1 | $37K | Sell |
644
-299
| -32% | -$17K | ﹤0.01% | 2492 |
|
|
2019
Q4 | $54K | Hold |
943
| – | – | ﹤0.01% | 2449 |
|
|
2019
Q3 | $50K | Sell |
943
-25
| -3% | -$1.46K | ﹤0.01% | 2469 |
|
|
2019
Q2 | $58K | Sell |
968
-576
| -37% | -$36.2K | ﹤0.01% | 2461 |
|
|
2019
Q1 | $96K | Sell |
1,544
-358
| -19% | -$23.7K | ﹤0.01% | 2213 |
|
|
2018
Q4 | $116K | Sell |
1,902
-335
| -15% | -$20K | ﹤0.01% | 2036 |
|
|
2018
Q3 | $131K | Sell |
2,237
-250
| -10% | -$12.8K | ﹤0.01% | 2088 |
|
|
2018
Q2 | $112K | Buy |
2,487
+9
| +0.4% | +$387 | ﹤0.01% | 2177 |
|
|
2018
Q1 | $110K | Sell |
2,478
-426
| -15% | -$17.9K | ﹤0.01% | 2186 |
|
|
2017
Q4 | $125K | Sell |
2,904
-362
| -11% | -$16.3K | ﹤0.01% | 2148 |
|
|
2017
Q3 | $152K | Sell |
3,266
-189
| -5% | -$9.05K | ﹤0.01% | 2007 |
|
|
2017
Q2 | $171K | Buy |
3,455
+36
| +1% | +$1.89K | ﹤0.01% | 1921 |
|
|
2017
Q1 | $188K | Sell |
3,419
-104
| -3% | -$5.5K | ﹤0.01% | 1851 |
|
|
2016
Q4 | $196K | Buy |
3,523
+53
| +2% | +$2.55K | ﹤0.01% | 1797 |
|
|
2016
Q3 | $158K | Buy |
3,470
+445
| +15% | +$17.9K | ﹤0.01% | 1859 |
|
|
2016
Q2 | $121K | Buy |
3,025
+525
| +21% | +$19.2K | ﹤0.01% | 1942 |
|
|
2016
Q1 | $87K | Buy |
2,500
+113
| +5% | +$4.15K | ﹤0.01% | 2093 |
|
|
2015
Q4 | $103K | Sell |
2,387
-126
| -5% | -$6.31K | ﹤0.01% | 2052 |
|
|
2015
Q3 | $109K | Sell |
2,513
-54
| -2% | -$2.91K | ﹤0.01% | 2037 |
|
|
2015
Q2 | $132K | Buy |
2,567
+46
| +2% | +$1.96K | ﹤0.01% | 1979 |
|
|
2015
Q1 | $99K | Hold |
2,521
| – | – | ﹤0.01% | 2168 |
|
|
2014
Q4 | $97K | Buy |
2,521
+732
| +41% | +$27.9K | ﹤0.01% | 2160 |
|
|
2014
Q3 | $63K | Hold |
1,789
| – | – | ﹤0.01% | 2370 |
|
|
2014
Q2 | $48K | Hold |
1,789
| – | – | ﹤0.01% | 2501 |
|
|
2014
Q1 | $46K | Hold |
1,789
| – | – | ﹤0.01% | 2523 |
|
|
2013
Q4 | $39K | Sell |
1,789
-47
| -3% | -$962 | ﹤0.01% | 2526 |
|
|
2013
Q3 | $36K | Hold |
1,836
| – | – | ﹤0.01% | 2469 |
|
|
2013
Q2 | $29K | Buy |
+1,836
| New | +$29.5K | ﹤0.01% | 2520 |
|
Other funds holding BSTC
US Bancorp's BSTC Position: Q4 2020 in Review
US Bancorp sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 594 shares — an estimated $31K sold.
US Bancorp first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $196K in Q4 2016. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- US Bancorp reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- US Bancorp sold 594 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $31K.
- US Bancorp first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- US Bancorp's BioSpecifics Technologies Corp. position peaked at $196K in Q4 2016.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.